StockIQ.techZoetis Inc. (ZTS) Stock Analysis
Free AI-powered analysis and research for Zoetis Inc. stock
Sector: Healthcare
ZTS snapshot
Data as of 9 Oct 2026 close. Updated daily.
Zoetis Inc. scores 67/100 on StockIQ's model, which reads as positive signals overall. The price is below its 200-day average and at 8% of its 52-week range, down 47.0% over the past year. Latest reported figures show a profit margin of 27.7%, return on equity of 64.9% and revenue growth of -0.2%.
What is driving the score
- Short-term Uptrend: +6
- MACD Bullish: +8
- Low P/E (12.0): +10
- Excellent Profit Margin (27.7%): +10
- High Debt (2.94 D/E): -10
- Strong Liquidity (3.08 Current Ratio): +8
- Excellent ROE (64.9%): +8
- High P/B (9.32): -5
- Long-term Downtrend: -8
- Severe Underperformance (-47.0% over 1 year): -10
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full ZTS report
Zoetis Inc. (ZTS) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze ZTS Now →📰 Latest Update
Zoetis Declares Fourth Quarter 2026 Dividend
Thu, October 8, 2026 at 8:15 PM UTC 4 min read
Zoetis (ZTS) has declared a dividend for the fourth quarter of 2026, signaling its commitment to returning value to shareholders. This move is significant for investors as it reflects the company's strong financial health and consistent cash flow generation, which can enhance investor confidence and potentially attract more long-term investors. The dividend announcement underscores Zoetis' strategy to maintain shareholder returns amidst a competitive market.